Literature DB >> 2306831

Frequency-dependent effects of quinidine on the ventricular action potential and QRS duration in humans.

K Nademanee1, W G Stevenson, J N Weiss, V B Frame, M G Antimisiaris, T Suithichaiyakul, C M Pruitt.   

Abstract

We studied the frequency-dependent effects of quinidine on the right ventricular action potential and QRS duration in 10 patients (nine men and one woman; mean age, 57 +/- 14 years) undergoing electrophysiologic studies for clinical indications. The right ventricular monophasic action potential, electrocardiographic, and conventional intracardiac electrical signals from various sites were recorded at different pacing cycle lengths from 30 seconds to 1 minute before and after a 10-mg/kg i.v. quinidine infusion. We used the extrastimulus technique to determine the effects of quinidine on ventricular refractory periods at different pacing cycle lengths and on the abrupt changes of the action potential duration. The action potential duration progressively decreased as the ventricular pacing rate increased at baseline and after quinidine infusion. Quinidine significantly increased the action potential duration from that of control by 25 msec (p less than 0.02) at the relatively slow pacing cycle lengths of 600, 500, and 400 msec. Quinidine's effect on the action potential duration was attenuated at the pacing cycle length of 350 msec and became negligible at 300 msec. In contrast, quinidine progressively lengthened the QRS duration as the pacing rate increased (20, 18, 37, 46, and 34 msec at pacing cycle lengths of 600, 500, 400, 350, and 300 msec, respectively; p less than 0.05). There were no rate-dependent changes in the QRS duration during the control period. The relation between the ventricular refractory periods and the action potential duration at different pacing cycle lengths was also determined before and after quinidine infusion.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2306831     DOI: 10.1161/01.cir.81.3.790

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

1.  Assessment of frequency dependency of the class III effects of almokalant: a study using programmed stimulation and recording of monophasic action potentials and ventricular paced QT intervals.

Authors:  B Darpö; O Almgren; R Bergstrand; S Franzén; N Edvardsson
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

2.  [Torsade de pointes tachycardia during administration of quinidine and verapamil in atrial fibrillation].

Authors:  M Karch; C Schmitt; A Plewan; G Schmidt; A Schömig
Journal:  Herz       Date:  1997-02       Impact factor: 1.443

3.  Human ex-vivo action potential model for pro-arrhythmia risk assessment.

Authors:  Guy Page; Phachareeya Ratchada; Yannick Miron; Guido Steiner; Andre Ghetti; Paul E Miller; Jack A Reynolds; Ken Wang; Andrea Greiter-Wilke; Liudmila Polonchuk; Martin Traebert; Gary A Gintant; Najah Abi-Gerges
Journal:  J Pharmacol Toxicol Methods       Date:  2016-05-25       Impact factor: 1.950

Review 4.  Mechanobiology Assays with Applications in Cardiomyocyte Biology and Cardiotoxicity.

Authors:  Cheavar A Blair; Beth L Pruitt
Journal:  Adv Healthc Mater       Date:  2020-04-09       Impact factor: 9.933

5.  Direct quantification of apparent binding indices from quinidine-induced in vivo conduction delay in canine myocardium.

Authors:  F N Haugland; S B Johnson; D L Packer
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

6.  Buflomedil poisoning: five cases with cardiotoxicity.

Authors:  A Legras; R Piquemal; Y Furet; P F Dequin; D Perrotin
Journal:  Intensive Care Med       Date:  1996-01       Impact factor: 17.440

7.  Atrial arrhythmogenesis in wild-type and Scn5a+/delta murine hearts modelling LQT3 syndrome.

Authors:  Yana Dautova; Yanmin Zhang; Ian Sabir; Andrew A Grace; Christopher L-H Huang
Journal:  Pflugers Arch       Date:  2009-01-28       Impact factor: 3.657

8.  Quantitative Comparison of Effects of Dofetilide, Sotalol, Quinidine, and Verapamil between Human Ex vivo Trabeculae and In silico Ventricular Models Incorporating Inter-Individual Action Potential Variability.

Authors:  Oliver J Britton; Najah Abi-Gerges; Guy Page; Andre Ghetti; Paul E Miller; Blanca Rodriguez
Journal:  Front Physiol       Date:  2017-08-18       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.